Certified by Founder Lodge
Omega Funds
United States - Boston, Massachusetts
INVESTOR
1 Disclosed Funding Rounds $60,000,000
15 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world’s most urgent medical needs.
Ω is the last letter of the Gr
| Company | Date | Round | Raised |
|---|---|---|---|
 EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
 SoniVie Ltd |
January, 17 ,2023 | Series C | $60,000,000 |
 Alumis |
March, 07 ,2024 | Series C | $259,000,000 |
 Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
 Beta Bionics |
September, 04 ,2023 | Series D | $100,000,000 |
 Marea Therapeutics |
June, 20 ,2024 | Series A | $190,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
 CatalYm GmbH |
July, 16 ,2024 | Series D | $150,000,000 |
| Alumis |
March, 07 ,2024 | Series C | $259,000,000 |
 Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| Marea Therapeutics |
June, 20 ,2024 | Series A | $190,000,000 |
 XII Medical |
August, 22 ,2024 | Series B | $45,000,000 |
| CatalYm GmbH |
July, 16 ,2024 | Series D | $150,000,000 |
| Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| XII Medical |
August, 22 ,2024 | Series B | $45,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
